Breast cancer impacts various spheres of the patient's life and their family and social environment. It is a complex disease that requires a multidisciplinary approach both for diagnosis and treatment, as well as for managing mediate and late toxicity from systemic treatment and radiotherapy, as well as psychological aspects. Palliative care and pain management are being incorporated earlier and earlier into treatment for the benefit of patients. Geneticists have now been incorporated into this multidisciplinary approach due to advances in genotyping and targeted therapies. The dissemination of this consensus contributes to the updating and homogeneity of breast cancer management criteria and the objective of this article is to present the update on the multidisciplinary management of breast cancer.